Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
William T. Andrews currently holds 34,250 shares of Flexion Therapeutics Inc (FLXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William T. Andrews has been a net neutral trader of FLXN stock. They have purchased $0 and sold $0 worth of shares.
William T. Andrews's most recent insider trade was on Nov 19, 2021, when they sold 34,250 shares at $8.50 per share.
William T. Andrews serves as Executive at Flexion Therapeutics Inc (FLXN). They have executed 6 insider transactions totaling $0 over their tenure at the company.
William T. Andrews holds the position of Executive at Flexion Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
William T. Andrews has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by William T. Andrews was on Oct 12, 2020, when they sold $680.6K worth of AKCA shares. This transaction involved 37,500 shares at $18.15 per share.
William T. Andrews currently owns 34,250 shares of Flexion Therapeutics Inc (FLXN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of William T. Andrews's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. William T. Andrews has 6 Form 4 filings on record as an insider at Flexion Therapeutics Inc.
Set alerts for William T. Andrews and 40,000+ other insiders.